WMT
124.35
+0.19%↑
COST
998.63
-0.14%↓
TGT
121.7
+1.71%↑
KR
70.25
-4.16%↓
DG.US
120.73
+2.18%↑
WMT
124.35
+0.19%↑
COST
998.63
-0.14%↓
TGT
121.7
+1.71%↑
KR
70.25
-4.16%↓
DG.US
120.73
+2.18%↑
WMT
124.35
+0.19%↑
COST
998.63
-0.14%↓
TGT
121.7
+1.71%↑
KR
70.25
-4.16%↓
DG.US
120.73
+2.18%↑
WMT
124.35
+0.19%↑
COST
998.63
-0.14%↓
TGT
121.7
+1.71%↑
KR
70.25
-4.16%↓
DG.US
120.73
+2.18%↑
WMT
124.35
+0.19%↑
COST
998.63
-0.14%↓
TGT
121.7
+1.71%↑
KR
70.25
-4.16%↓
DG.US
120.73
+2.18%↑
24h
Praegune
Min
9.46
Max
10.09
Sissetulek | 46M -19M |
|---|---|
Müük | 11M 234M |
Aktsiakasum | -0.024 |
Kasumimarginaal | -8.189 |
Töötajad | 1,388 |
EBITDA | 28M -8.1M |
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +53.33% upside |
Turukapital | -31M 309M |
|---|---|
Eelmine avamishind | 7.19 |
Eelmine sulgemishind | 9.97 |
By Trading Central
Kindlus
Weak Bullish Evidence
8.26 / 8.69 Toetus ja vastupanu
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
31. märts 2026, 23:31 UTC
Stocks to Watch: Nike, RH, NCino
DJ
Loe
31. märts 2026, 22:35 UTC
Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update
DJ
Loe
1. apr 2026, 00:00 UTC
The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ
DJ
Loe
31. märts 2026, 23:50 UTC
Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO
DJ
Loe
31. märts 2026, 23:43 UTC
Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk
DJ
Loe
31. märts 2026, 23:33 UTC
Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk
DJ
Loe
31. märts 2026, 23:21 UTC
Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com
DJ
Loe
31. märts 2026, 23:14 UTC
Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk
DJ
Loe
31. märts 2026, 23:12 UTC
Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk
DJ
Loe
31. märts 2026, 22:36 UTC
China Vanke 2025 Loss Widens >000002.SZ
DJ
Loe
31. märts 2026, 22:36 UTC
China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ
DJ
Loe
31. märts 2026, 22:36 UTC
China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ
DJ
Loe
31. märts 2026, 22:36 UTC
China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ
DJ
Loe
31. märts 2026, 22:36 UTC
China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ
DJ
Loe
31. märts 2026, 21:46 UTC
Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ
DJ
Loe
31. märts 2026, 21:36 UTC
West African Resources's Costs Higher Than Bull Expected -- Market Talk
DJ
Loe
31. märts 2026, 21:35 UTC
Nike Expects China Sales Down 20% in 4Q, CFO Says
DJ
Loe
31. märts 2026, 21:35 UTC
Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says
DJ
Loe
31. märts 2026, 21:35 UTC
Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says
DJ
Loe
31. märts 2026, 21:33 UTC
Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com
DJ
Loe
31. märts 2026, 21:33 UTC
Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says
DJ
Loe
31. märts 2026, 21:32 UTC
Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says
DJ
Loe
31. märts 2026, 21:28 UTC
Nike Expects to End 4Q With Elevated Inventory, CFO Says
DJ
Loe
31. märts 2026, 21:26 UTC
Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says
DJ
Loe
31. märts 2026, 21:25 UTC
Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says
DJ
Loe
31. märts 2026, 21:24 UTC
Nike: Turnaround Plan Progressing at Different Rates -- Market Talk
DJ
Loe
31. märts 2026, 21:22 UTC
Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters
DJ
Loe
31. märts 2026, 21:22 UTC
Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says
DJ
Loe
31. märts 2026, 21:21 UTC
Nike's Digital Channel Still Too Promotional, CFO Says
DJ
Loe
31. märts 2026, 21:20 UTC
Nike CEO: Converse Remains Important to Portfolio
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 14.75 USD 53.33%
Kõrge 15 USD
Madal 14.5 USD
Põhineb 2 Wall Streeti analüütiku instrumendi Oatly Group AB ADR 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
2 ratings
1
Osta
1
Hoia
0
Müü
Põhineb 2 analüütiku instrumendi Oatly Group AB ADR aktsia reitingul - viimase 3 kuu andmed.
By Trading Central
Lühikene perspektiiv
Weak Bullish Evidence
Bullish events outweigh bearish events.
Keskpikk perspektiiv
Bearish Evidence
All events are bearish.
Pikk perspektiiv
Weak Bearish Evidence
There is one bearish event.
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$